Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Operating activities:
Net income	$ 10,311	$ 10,223
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	1,933	1,901
Provision for loan losses	13,125	9,812
Provision for indemnification	243	212
Provision for other real estate owned losses	106	90
Share-based compensation	914	779
Net accretion of certain acquisition-related fair value adjustments	(1,202)	(1,562)
Accretion of discounts and amortization of premiums on securities, net	1,237	1,162
Realized gains on sales and calls of securities	(48)	(25)
Net realized gains on sales of other real estate owned	(110)	(242)
Net realized gains on sale of corporate premises and equipment	(183)	(37)
Increase in bank-owned life insurance cash surrender value	(754)	(263)
Origination of loans held for sale	(485,361)	(423,999)
Proceeds from sales of loans held for sale	469,253	413,199
Gains on sales of loans held for sale	(6,581)	(4,803)
Change in other assets and liabilities:
Accrued interest receivable	278	(233)
Other assets	(6,142)	(76)
Accrued interest payable	(26)	(53)
Other liabilities	5,217	1,417
Net cash provided by operating activities	2,210	7,502
Investing activities:
Proceeds from maturities, calls and sales of securities available for sale	48,296	24,402
Purchases of securities available for sale	(33,888)	(24,960)
Net (redemptions) issuance of restricted stocks	(58)	97
Purchase of loan portfolio		(16,258)
Net increase in loans	(82,130)	(36,175)
Other real estate owned improvements	(20)
Proceeds from sales of other real estate owned	1,085	705
Purchases of corporate premises and equipment, net	(1,732)	(1,000)
Net cash used in investing activities	(68,447)	(53,189)
Financing activities:
Net increase in demand, interest-bearing demand and savings deposits	9,333	43,987
Net increase (decrease) in time deposits	6,162	(27,966)
Net (decrease) increase in borrowings	(10,085)	11,897
Issuance of common stock	350	101
Purchase of common stock	(155)	(1,479)
Cash dividends	(3,316)	(3,054)
Net cash provided by financing activities	2,289	23,486
Net decrease in cash and cash equivalents	(63,948)	(22,201)
Cash and cash equivalents at beginning of period	152,943	167,616
Cash and cash equivalents at end of period	88,995	145,415
Supplemental disclosure
Interest paid	6,710	6,817
Income taxes paid	2,142	450
Supplemental disclosure of noncash investing and financing activities
Unrealized gains (losses) on securities available for sale	1,183	(850)
Transfers from loans to other real estate owned	618	3,814
Pension adjustment	69	(45)
Unrealized losses on cash flow hedging instruments	$ (428)	$ (431)